Form 4 for ADCT ADC Therapeutics SA
Accepted 2025-02-14 00:00:00 ET · period of report 2025-02-13 · accession 0001628280-25-005859 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-14 | 2025-02-13 | ADCT | MALLIK AMEET | CEO, Dir | A - Grant | $1.61 | +650.0K | 1.58M | +70% | +$1.05M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2025-02-13 | A | A | 650,000 | $1.61 | 1,579,005 | D | — | — | (F1) Represents Common Shares to be delivered in settlement of a restricted share unit award which vests one-third on the first anniversary of the grant date, which grant date is February 13, 2025, and then one-third on each anniversary date thereafter, upon continued service through the designated vesting event. |